Moderate Evidence (L3-L4)
Candidates with preliminary evidence that require further validation
Criteria
| Level | Definition | Clinical meaning |
|---|---|---|
| L3 | Observational studies / large case series | Preliminary support; needs further validation |
| L4 | Preclinical / mechanistic studies | Theoretical support; far from clinical use |
L3 (21 drugs)
| Drug | Indications | Link |
|---|---|---|
| Abatacept | 7 | View report |
| Acitretin | 4 | View report |
| Alprazolam | 2 | View report |
| Brentuximab Vedotin | 10 | View report |
| Calcipotriol | 10 | View report |
| Clobetasol | 1 | View report |
| Clonazepam | 3 | View report |
| Dupilumab | 9 | View report |
| Estriol | 1 | View report |
| Flecainide | 9 | View report |
| Hyaluronic Acid | 9 | View report |
| Imipramine | 7 | View report |
| Lenvatinib | 5 | View report |
| Magnesium Sulfate | 8 | View report |
| Medroxyprogesterone Acetate | 6 | View report |
| Mercaptopurine | 8 | View report |
| Nitroglycerin | 4 | View report |
| Oxazepam | 1 | View report |
| Propantheline | 1 | View report |
| Sofosbuvir | 8 | View report |
| Tocilizumab | 5 | View report |
L4 (45 drugs)
| Drug | Indications | Link |
|---|---|---|
| Arginine | 1 | View report |
| Axitinib | 4 | View report |
| Betamethasone | 7 | View report |
| Bicalutamide | 10 | View report |
| Bosentan | 8 | View report |
| Cyproterone Acetate | 9 | View report |
| Cytarabine | 9 | View report |
| Desvenlafaxine | 8 | View report |
| Dolutegravir | 3 | View report |
| Elvitegravir | 3 | View report |
| Entecavir | 9 | View report |
| Ephedrine | 2 | View report |
| Ethanol | 2 | View report |
| Febuxostat | 3 | View report |
| Folic Acid | 1 | View report |
| Fulvestrant | 10 | View report |
| Gemfibrozil | 9 | View report |
| Lamivudine | 5 | View report |
| Lopinavir | 3 | View report |
| Methadone | 7 | View report |
| Miconazole | 1 | View report |
| Nicorandil | 6 | View report |
| Oxcarbazepine | 1 | View report |
| Phenylephrine | 2 | View report |
| Pibrentasvir | 10 | View report |
| Potassium Chloride | 1 | View report |
| Potassium Iodide | 1 | View report |
| Pramipexole | 10 | View report |
| Pravastatin | 6 | View report |
| Probenecid | 3 | View report |
| Progesterone | 6 | View report |
| Propylthiouracil | 2 | View report |
| Raltegravir | 3 | View report |
| Ribociclib | 4 | View report |
| Rifampicin | 10 | View report |
| Ritonavir | 3 | View report |
| Tenofovir Alafenamide | 3 | View report |
| Tenofovir Disoproxil | 4 | View report |
| Tobramycin | 10 | View report |
| Triamcinolone | 8 | View report |
| Valine | 10 | View report |
| Valsartan | 6 | View report |
| Velpatasvir | 10 | View report |
| Vinblastine | 10 | View report |
| Zinc Oxide | 5 | View report |
Disclaimer
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)
This report is for academic research reference only and does not constitute medical advice. Always follow your physician's instructions; never adjust medication on your own. Any drug repurposing decision requires full clinical validation and regulatory review.
Reviewed by: 藥提醒科技有限公司 (yao.care)